CIP2A and neoplasm: While we do not know the precise reason for the discrepancy, we note that both Teng et al. [14] and our study assigned a relatively high percentage of patients to the low expression group (68 and 50% respectively), whereas Böckelman et al. [13] defined only 15% of patients as low CIP2A expression tumours.